Evidence map›Paper›PMID 33389326›Full record

ArticleAIDS and behavior2021

The Effect of Partnership Presence and Support on HIV Viral Suppression Among Serodiscordant Partnered and Single Heterosexual HIV-Positive Individuals in Brazil.

Zoë Baker, Pamina Gorbach, Marineide Gonçalves de Melo, Ivana Varela, Eduardo Sprinz, Breno Santos, Tauí de Melo Rocha, Mariana Simon, Marcelo Almeida, Rita Lira and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Zoë BakerDivision of Urology, Children's Hospital Los Angeles, 4650 W. Sunset Blvd, MS #114, Los Angeles, CA, 90027, USA. zobaker@chla.usc.edu.ORCID http://orcid.org/0000-0003-4929-1964
Pamina GorbachDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Marineide Gonçalves de MeloHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Ivana VarelaHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Eduardo SprinzHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Breno SantosHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Tauí de Melo RochaHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Mariana SimonHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Marcelo AlmeidaHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Rita LiraHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Maria Cristina ChavesHospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
Tara KerinDepartment of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Karin Nielsen-SainesDepartment of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Hospital Nossa Senhora da Conceição · BRUniversity of California, Los Angeles · USChildren's Hospital of Los Angeles · US

Funding

UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
UCLA AIDS Prevention and Treatment Clinical Trials UnitU01AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2007 to 2011
$13.9M
National Institute of Allergy and Infectious Diseases AI28697NIAID NIH HHS P30 AI028697NIAID NIH HHS U01 AI069424NIAID NIH HHS UM1 AI069424
6 · The paper itself

Abstract

HIV-negative individuals in serodiscordant partnerships experience reduced risk of HIV acquisition when their partners adhere to ART and achieve undetectable viral loads. Partnership support may encourage ART adherence, reducing viral load and the risk of HIV transmission. This study aims to determine whether HIV viral suppression is associated with partnership status and partnership support among 201 HIV positive (HIV+ individuals in serodiscordant partnerships and 100 HIV+ unpartnered individuals receiving care at Hospital Nossa Senhora da Conceição in Porto Alegre, Brazil between 2014 and 2016. Clinical data and patient-reported questionnaire data were assessed, and propensity scores were used to control for confounding variables in adjusted logistic regression models. Viral suppression did not significantly differ between HIV+ partnered (78.5% virally suppressed) and unpartnered (76.0% virally suppressed) individuals. Among individuals in partnerships, viral suppression was significantly associated with having a partner who attended monthly clinic visits (AOR 2.99; 95% CI 1.00-8.93). Instrumental social support-attending monthly visits-may improve the odds of viral suppression among HIV+ individuals in serodiscordant relationships.

Indexed as

Anti-HIV AgentsHIV InfectionsBrazilHeterosexualityHumansSexual PartnersViral LoadAnti-HIV AgentsAdherenceARTHIVPartnershipViral load

Identifiers

PMID33389326
PMCPMC7778561
OpenAlexW3121108386

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.